TY-011

N/A

Report date: 2022/01/05 15:24:33

NME

Base Information

Drug NameTY-011

Drug Alias NameTY-011

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase Aurora-A inhibitorsVascular endothelial growth factor receptor 2 inhibitorsSerine/threonine-protein kinase Aurora-B inhibitors

TargetsSerine/threonine-protein kinase Aurora-ASerine/threonine-protein kinase Aurora-BVascular endothelial growth factor receptor 2

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesNanjing Tianyi Biological Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesNanjing Tianyi Biological Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A